Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Friedmann

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Israel Journal of Medical Sciences|May 1, 1982
Blood pressure changes while talkingJ J Lynch, S A Thomas, J M Long, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|January 20, 2007
Quality of life and psychological status of patients with implantable cardioverter defibrillatorsE Friedmann, S A Thomas, P Inguito, et al.
Annals of Epidemiology|March 1, 1996
Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST)D Obias-Manno, E Friedmann, M M Brooks, et al.
Cell Death and Differentiation|June 9, 2007
The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cellsV Kirkin, N Cahuzac, F Guardiola-Serrano, et al.
Current Oncology (Toronto, Ont.)|November 24, 2022
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic CenterGoulnar Kasymjanova, Angelo Rizzolo, Carmela Pepe, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single CentreAnna-Maria Lazaratos, Matthew Dankner, Aalya Hamouda, et al.
Journal for Immunotherapy of Cancer|November 22, 2017
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanomaRahima Jamal, Réjean Lapointe, Eftihia Cocolakis, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Israel Journal of Medical Sciences|May 1, 1982
Blood pressure changes while talkingJ J Lynch, S A Thomas, J M Long, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|January 20, 2007
Quality of life and psychological status of patients with implantable cardioverter defibrillatorsE Friedmann, S A Thomas, P Inguito, et al.
Annals of Epidemiology|March 1, 1996
Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST)D Obias-Manno, E Friedmann, M M Brooks, et al.
Cell Death and Differentiation|June 9, 2007
The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cellsV Kirkin, N Cahuzac, F Guardiola-Serrano, et al.
Current Oncology (Toronto, Ont.)|November 24, 2022
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic CenterGoulnar Kasymjanova, Angelo Rizzolo, Carmela Pepe, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single CentreAnna-Maria Lazaratos, Matthew Dankner, Aalya Hamouda, et al.
Journal for Immunotherapy of Cancer|November 22, 2017
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanomaRahima Jamal, Réjean Lapointe, Eftihia Cocolakis, et al.
Pageof 5